Effects of Immunonutrition on Comprehensive Complication Index in Patients Undergoing Pancreatoduodenectomy

Effects of Immunonutrition on Comprehensive Complication Index in Patients Undergoing Pancreatoduodenectomy

<i>Background and objectives:</i> Immunonutrition is recommended by enhanced recovery after surgery in patients undergoing pancreatoduodenectomy for 5−7 days perioperatively as it may reduce the rate of infectious complications. However, data on effect of immunonutrition on the...

Full description

Bibliographic Details
Main Authors:	Jaroslav Tumas, Eugenijus Jasiūnas, Kęstutis Strupas, Audrius Šileikis
Format:	Article
Language:	English
Published:	MDPI AG 2020-01-01
Series:	Medicina
Subjects:	pancreatic ductal adenocarcinoma pancreatoduodenal resection outcomes pancreatic tumour nutritional impairments
Online Access:	https://www.mdpi.com/1010-660X/56/2/52

Similar Items

Pancreatoduodenal resection in the treatment of complicated forms chronic pancreatitis
by: N. N. Veligotsky, et al.
Published: (2021-12-01)

THE RESULTS OF THE PANCREATODUODENECTOMY IN THE SPECIALIZED DEPARTMENT OF A GENERAL HOSPITAL
by: M. L. Rogal, et al.
Published: (2016-03-01)

Method of formation of pancreatoenteroanastomosis in pancreatoduodenal resection
by: S. V. Tarasenko, et al.
Published: (2017-06-01)

The first experience of applying a new pancreatoenteroanastomosis with a «soft» pancreatic stump in pancreatoduodenal resection
by: A. Yu. Barannikov, et al.
Published: (2022-11-01)

Cystic Form of Duodenal Dystrophy (Clinical Case)
by: D. E. Okonskaya, et al.
Published: (2023-08-01)

Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma
by: Tomonari Shimagaki, et al.
Published: (2023-11-01)

Experience of using MRT imaging in specifying diagnosis of obstructive diseases of the biliopancreatoduodenal zone.
by: B. S. Zaporozhchenko, et al.
Published: (2018-12-01)

PALLIATIVE PANCREATODUODENAL RESECTION IN PANCREATIC HEAD CANCER
by: T. G. Gevorkyan, et al.
Published: (2018-03-01)

ULTRASOUND ELASTOMETRY OF THE PANCREAS IN A DIFFERENTIATED APPROACH TO THE FORMATION OF PANCREATOENTEROANASTOMOSIS IN PANCREATODUODENAL RESECTION
by: A. Yu. BARANNIKOV, et al.
Published: (2018-10-01)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
by: Quisette P. Janssen, et al.
Published: (2020-01-01)

New Frontiers in Pancreatic Cancer Management: Current Treatment Options and the Emerging Role of Neoadjuvant Therapy
by: Sofia Dallavalle, et al.
Published: (2024-06-01)

Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver
by: Tomohiko Taniai, et al.
Published: (2018-08-01)

Adjuvant 5‐fluorouracil and portal vein infusion chemotherapy followed by gemcitabine for pancreatic cancer
by: Minoru Kitago, et al.
Published: (2024-07-01)

Differential diagnosis of pancreatic cancer and chronic pseudotumor pancreatitis: literature review
by: A. A. Perminova, et al.
Published: (2024-02-01)

Comparative Analysis of the Results of Various Methods for Pancreatic Head Resection in Chronic Pancreatitis
by: A. R. Propp, et al.
Published: (2020-10-01)

Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors—Literature Review
by: Aiste Gulla, et al.
Published: (2022-06-01)

Realising the therapeutic potential of the human microbiota in metastatic pancreatic ductal adenocarcinoma
by: James M. Halle-Smith, et al.
Published: (2023-12-01)

Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives
by: Alessandro Coppola, et al.
Published: (2022-08-01)

A CT-based diagnostic nomogram and survival analysis for differentiating grade 3 pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas
by: Miaomiao Hu, et al.
Published: (2024-08-01)

Textbook outcomes among patients undergoing curative resection of pancreatic ductal adenocarcinoma in the era of neoadjuvant therapy
by: Lingyu Zhu, et al.
Published: (2023-06-01)

Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases
by: Takuya Mizumoto, et al.
Published: (2017-05-01)

Conventional partial pancreatoduodenectomy versus an extended pancreatoduodenectomy (triangle operation) for pancreatic head cancers—study protocol for the randomised controlled TRIANGLE trial
by: Patrick Heger, et al.
Published: (2023-05-01)

Pancreatic index: A prognostic factor of upfront surgery for body or tail pancreatic ductal adenocarcinoma with vascular involvement—A retrospective study
by: Lihan Qian, et al.
Published: (2023-12-01)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)

Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01)

Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study
by: Naohiro Kato, et al.
Published: (2023-05-01)

Pancreatic tail cancer in the setting of pancreatitis with a review of the literature: A case report
by: Shinji Rho, et al.
Published: (2023-10-01)

АУТОИММУННЫЙ ПАНКРЕАТИТ
by: Н. С. Гаврилина, et al.
Published: (2014-06-01)

Feasibility of laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer: a retrospective cohort study
by: Zheng Li, et al.
Published: (2024-01-01)

Analysis of preoperative risk factors for early recurrence after curative pancreatoduodenectomy for resectable pancreatic adenocarcinoma
by: Burasakarn Pipit, et al.
Published: (2022-06-01)

Oncological Outcomes of Open Versus Minimally Invasive Surgery for Ductal Adenocarcinomas of Pancreatic Head: A Propensity Score Matching Analysis
by: Alessandro Giani, et al.
Published: (2024-10-01)

Impact of Aspirin Intake on Postoperative Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma—A Single-Center Evaluation
by: Danilo Hackner, et al.
Published: (2023-05-01)

Neoadjuvant Treatment of Borderline Resectable Pancreatic Cancer
by: CHEN Zegang, et al.
Published: (2022-09-01)

Sonic Hedgehog Ligand: A Role in Formation of a Mesenchymal Niche in Human Pancreatic Ductal Adenocarcinoma
by: Francesca Saini, et al.
Published: (2019-05-01)

Impact of tumour associated macrophages in pancreatic cancer
by: Ainhoa Mielgo, et al.
Published: (2013-03-01)

Pancreas CT assessment for pancreatic ductal adenocarcinoma resectability: effect of tube voltage and slice thickness on image quality and diagnostic performance
by: Dong Ho Lee, et al.
Published: (2023-12-01)

Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
by: Jingshu Tong, et al.
Published: (2022-11-01)

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study
by: Siyi Zou, et al.
Published: (2022-06-01)

PREOPERATIVE BILIARY DECOMPRESSION IN PATIENTS WITH OBSTRUCTIVE JAUNDICE AS A WAY TO PREVENT THE DEVELOPMENT OF POSTOPERATIVE INFLAMMATORY COMPLICATIONS IN PANCREATODUODENECTOMY
by: E. Kh. Baychorov, et al.
Published: (2014-06-01)

Microbiome in pancreatic cancer – What is new in 2024?
by: E. Hohmann, et al.
Published: (2024-10-01)